Istituto di Ricerche Farmacologiche Mario Negri IRCCS (Italy) • I obtained a master’s degree in Biomolecular Chemistry at the University of Catania in 2011. In 2014, I was awarded the title of Biomedical Research Specialist at the IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. I used the nematode Caenorhabditis elegans as an innovative animal model to investigate the molecular mechanism involved in central or systemic amyloidosis. In 2019, I obtained a Phd at the IRCCS Istituto di Ricerche Farmacologiche Mario Negri. The project aimed to investigate the molecular mechanisms underlying the ability of C. elegans’ pharynx to recognize toxicant cardiotoxic light chains that cause heart damage in patients suffering from immunoglobulin light chain amyloidosis. In particular, I investigated the crucial role of metal ions, particularly copper, in driving the ROS-mediated proteotoxic effects of light chains. I then moved to the Institute of Clinical Chemistry and Laboratory Diagnostic Medical Faculty, Heinrich Heine University, and the IUF- Leibniz Research Institute for Environmental Medicine in Düsseldorf (Germany) to elucidate the role of AhR in aging in C.elegans and to describe the AhR-mitochondria cross-talk. From 2022 I am a post-doc at the IRCCS Istituto di Ricerche Farmacologiche Mario Negri of Milan (Italy), where I am focusing my research on clarifying the molecular mechanism involved in immunoglobulin light chains amyloidosis and developing new therapeutic strategies.